Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth

Cellular Physiology and Biochemistry

Volumn 27, Issue 3-4, 2011, Pages 243-250

  Caverzasio, Joseph ^a   Thouverey, Cyril ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Calcium sensing receptor; Cation sensing mechanism; Fibroblast growth factor signaling; Growth; MC3T3 E1; Primary calvaria derived osteoblast; Strontium ranelate

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; CALCIUM SENSING RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEOMYCIN; PROTEIN TYROSINE KINASE INHIBITOR; STRONTIUM RANELATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL GROWTH; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVATION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 79953777185     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000327950     Document Type: Article

References (32)

1. Meunier PJ: [strontium ranelate: New therapeutic agent for postmenopausal osteoporosis]. Med Sci (Paris) 2004;20:631-633.
2. Reginster JY, Sarlet N, Lejeune E, Leonori L: Strontium ranelate: A new treatment for postmenopausal osteoporosis with a dual mode of action. Curr Osteoporos Rep 2005;3:30-34.
3. Marie PJ, Ammann P, Boivin G, Rey C: Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 2001;69:121-129. (Pubitemid 32912229)
4. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ: The divalent strontium salt s12911 enhances bone cell replication and bone formation in vitro. Bone 1996;18:517-523. (Pubitemid 26257871)
5. Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R: Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 2007;22:1419-1425. (Pubitemid 351339686)
6. Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R: Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 2004;19:2012-2020. (Pubitemid 41103416)
7. Baron R, Tsouderos Y: In vitro effects of s12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 2002;450:11-17.
8. Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, Tsouderos Y: An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 1993;8:607-615. (Pubitemid 23127921)
9. Takahashi N, Sasaki T, Tsouderos Y, Suda T: S 12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 2003;18:1082-1087. (Pubitemid 37294946)
10. Bonnelye E, Chabadel A, Saltel F, Jurdic P: Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008;42:129-138. (Pubitemid 350297175)
11. Zhu LL, Zaidi S, Peng Y, Zhou H, Moonga BS, Blesius A, Dupin-Roger I, Zaidi M, Sun L: Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun 2007;355:307-311. (Pubitemid 46282628)
12. Brown EM, Chattopadhyay N, Yano S: Calcium-sensing receptors in bone cells. J Musculoskelet Neuronal Interact 2004;4:412-413. (Pubitemid 40124887)
13. Coulombe J, Faure H, Robin B, Ruat M: In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. Biochem Biophys Res Commun 2004;323:1184-1190.
14. Chattopadhyay N, Quinn SJ, Kifor O, Ye C, Brown EM: The calcium-sensing receptor (car) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol 2007;74:438-447. (Pubitemid 46970843)
15. Fromigue O, Hay E, Barbara A, Petrel C, Traiffort E, Ruat M, Marie PJ: Calcium sensing receptor-dependent and - independent activation of osteoblast replication and survival by strontium ranelate. J Cell Mol Med 2009;13,:2189-2199.
16. Caverzasio J: Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms. Bone 2008;42:1131-1136.
17. Bellows CG, Aubin JE, Heersche JN, Antosz ME: Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986;38:143-154. (Pubitemid 16160917)
18. Lemonnier J, Ghayor C, Guicheux J, Caverzasio J: Protein kinase c-independent activation of protein kinase d is involved in bmp-2-induced activation of stress mitogen-activated protein kinases jnk and p38 and osteoblastic cell differentiation. J Biol Chem 2004;279:259-264. (Pubitemid 38044823)
19. Marie PJ, Coffin JD, Hurley MM: Fgf and fgfr signaling in chondrodysplasias and craniosynostosis. J Cell Biochem 2005;96:888-896. (Pubitemid 41688715)
20. Tfelt-Hansen J, Brown EM: The calcium-sensing receptor in normal physiology and pathophysiology: A review. Crit Rev Clin Lab Sci 2005;42:35-70. (Pubitemid 41656709)
21. Canalis E, Raisz LG: Effect of fibroblast growth factor on cultured fetal rat calvaria. Metabolism 1980;29:108-114. (Pubitemid 10139549)
22. Jikihara H, Ikegami H, Sakata M, Morishige K, Fujita Y, Kurachi H, Miyake A, Tanizawa O, Terakawa N: Epidermal growth factor attenuates cell proliferation by down-regulating the transforming growth factor-beta receptor in the osteoblastic cell line mc3t3-e1. Bone Miner 1991;15:125-135.
23. Mehrotra M, Krane SM, Walters K, Pilbeam C: Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 2004;93:741-752. (Pubitemid 44264170)
24. Tille JC, Pepper MS: Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro. Exp Cell Res 2002;280:179-191.
25. Hurley MM, Marie PJ, Florkiewicz RZ: Fibroblast Growth Factor and Fibroblast Growth Factor Receptor Families in Bone: in Bilezikian J, Raisz LG, Rodan G. (eds): Principles of Bone Biology. San Diego, Academic Press, 2002, pp 825-851.
26. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM: Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 2000;105:1085-1093. (Pubitemid 30217693)
27. Patstone G, Maher P: Copper and calcium binding motifs in the extracellular domains of fibroblast growth factor receptors. J Biol Chem 1996;271:3343-3346. (Pubitemid 26065635)
28. Yokote H, Fujita K, Jing X, Sawada T, Liang S, Yao L, Yan X, Zhang Y, Schlessinger J, Sakaguchi K: Transactivation of epha4 and fgf receptors mediated by direct interactions between their cytoplasmic domains. Proc Natl Acad Sci U S A 2005;102:18866-18871. (Pubitemid 43049533)
29. Li X, Brunton VG, Burgar HR, Wheldon LM, Heath JK: Frs2-dependent src activation is required for fibroblast growth factor receptor-induced phosphorylation of sprouty and suppression of erk activity. J Cell Sci 2004;117:6007-6017. (Pubitemid 40123967)
30. Halford MM, Stacker SA: Revelations of the ryk receptor. Bioessays 2001;23:34-45. (Pubitemid 32100499)
31. Pi M, Quarles LD: A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. J Bone Miner Res 2004;19:862-869. (Pubitemid 41094398)
32. Yamaguchi T, Chattopadhyay N, Kifor O, Butters RR Jr, Sugimoto T, Brown EM: Mouse osteoblastic cell line (mc3t3-e1) expresses extracellular calcium (ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of mc3t3-e1 cells. J Bone Miner Res 1998;13:1530-1538. (Pubitemid 28465293)